Tools · Private company
MeMed Diagnostics Ltd.
Track this companyFree. Adds MeMed Diagnostics Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MeMed BV testLower Respiratory Tract InfectionClinicalTrials.gov · fetched Nov 12, 2026
- MeMed BV®Acute InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric CohortsCOMPLETED · started Jun 12, 2024ClinicalTrials.gov NCT06379061 · fetched Nov 12, 2026
- An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.NA · RECRUITING · started Dec 11, 2023ClinicalTrials.gov NCT06070688 · fetched Nov 12, 2026
- The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)NA · RECRUITING · started Jan 31, 2023ClinicalTrials.gov NCT05762302 · fetched Nov 12, 2026
- Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)COMPLETED · started Feb 11, 2022ClinicalTrials.gov NCT05439551 · fetched Nov 12, 2026
- A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.UNKNOWN · started Nov 12, 2020ClinicalTrials.gov NCT06665542 · fetched Nov 12, 2026
- Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY)COMPLETED · started May 3, 2019ClinicalTrials.gov NCT04690569 · fetched Nov 12, 2026